Alaunos Therapeutics Inc (TCRT) Ownership

$2.55

$0 (0%)
Last update: 09:43 AM EST
Day's range
$2.58
Day's range
$2.58

Alaunos Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 01/29/2026 30.06 K $97.10 K   43.34% 1.38%
BLACKROCK, INC. 02/12/2026 21.35 K $68.97 M   0.00% 0.98%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 19.74 K $63.76 K   24.98% 0.90%
TWO SIGMA INVESTMENTS, LP 02/17/2026 18.59 K $60.04 K   100.00% 0.85%
HRT FINANCIAL LP 02/12/2026 12.60 K $40.00 K   100.00% 0.58%
MORGAN STANLEY 02/13/2026 1.65 K $5.32 K   -2.20% 0.08%
UBS GROUP AG 01/29/2026 1.31 K $4.23 K   -14.61% 0.06%
TOWER RESEARCH CAPITAL LLC (TRC) 02/17/2026 1.08 K $3.49 K   -33.80% 0.05%
ADVISOR GROUP HOLDINGS, INC. 02/17/2026 1.08 K $3.47 K   -7.64% 0.05%
CIBC PRIVATE WEALTH GROUP, LLC 02/12/2026 300 $969   0.00% 0.01%
WELLS FARGO & COMPANY/MN 02/13/2026 178 $574   -2.73% 0.01%
RONALD BLUE TRUST, INC. 01/16/2026 135 $436   0.00% 0.01%
STEWARD PARTNERS INVESTMENT ADVISORY, LLC 02/12/2026 92 $297.00 K   0.00% 0.00%
BANK OF AMERICA CORP /DE/ 02/17/2026 89 $287   0.00% 0.00%
CITIGROUP INC 02/13/2026 89 $287   100.00% 0.00%
FEDERATION DES CAISSES DESJARDINS DU QUEBEC 02/12/2026 70 $226.00 K   0.00% 0.00%
KEY FINANCIAL INC 02/09/2026 24 $78   0.00% 0.00%
SIGNATUREFD, LLC 01/20/2026 23 $74   0.00% 0.00%
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. 01/21/2026 21 $68   -12.50% 0.00%
NBC SECURITIES, INC. 01/29/2026 20 $64   0.00% 0.00%
ADVISORNET FINANCIAL, INC 01/20/2026 19 $61   0.00% 0.00%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 6 $19   0.00% 0.00%
TIDEMARK, LLC 02/10/2026 2 $6   100.00% 0.00%
TUCKER ASSET MANAGEMENT LLC 02/05/2026 1 $3   100.00% 0.00%
BARCLAYS PLC 02/13/2026 0 $0   -100.00% 0.00%
ASSET DEDICATION, LLC 01/26/2026 0 $0   -100.00% 0.00%
WEALTHSPIRE ADVISORS, LLC 02/13/2026 0 $0   -100.00% 0.00%
TRUVESTMENTS CAPITAL LLC 02/13/2026 0 $0   -100.00% 0.00%

Alaunos Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 94 institutional investors and hedge funds held shares of Alaunos Therapeutics Inc. The most heavily invested institutionals were:

VANGUARD GROUP INC: 30,061

BlackRock, Inc.: 21,353

GEODE CAPITAL MANAGEMENT, LLC: 19,736

TWO SIGMA INVESTMENTS, LP: 18,588

HRT FINANCIAL LP: 12,602

MORGAN STANLEY: 1,647

1.45% of Alaunos Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 13.80 M shares in the last 24 months. This purchase volume represents approximately $35.19 M in transactions.